These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. Horst M; Hejjaoui A; Horst V; Michel FB; Bousquet J J Allergy Clin Immunol; 1990 Feb; 85(2):460-72. PubMed ID: 2406323 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy decreases skin sensitivity to cat extract. Van Metre TE; Marsh DG; Adkinson NF; Kagey-Sobotka A; Khattignavong A; Norman PS; Rosenberg GL J Allergy Clin Immunol; 1989 May; 83(5):888-99. PubMed ID: 2654256 [TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both. Purello-D'Ambrosio F; Gangemi S; Isola S; La Motta N; Puccinelli P; Parmiani S; Savi E; Ricciardi L Allergy; 1999 Sep; 54(9):968-73. PubMed ID: 10505460 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with cat- and dog-dander extracts. III. Allergen-specific immunoglobulin responses in a 1-year double-blind placebo study. Løwenstein H; Graff-Lonnevig V; Hedlin G; Heilborn H; Lilja G; Norrlind K; Pegelow KO; Sundin B J Allergy Clin Immunol; 1986 Mar; 77(3):497-505. PubMed ID: 2419384 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. Hedlin G; Graff-Lonnevig V; Heilborn H; Lilja G; Norrlind K; Pegelow K; Sundin B; Lowenstein H J Allergy Clin Immunol; 1991 May; 87(5):955-64. PubMed ID: 2026846 [TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of ALLERVAX CAT in cat allergic patients. Maguire P; Nicodemus C; Robinson D; Aaronson D; Umetsu DT Clin Immunol; 1999 Dec; 93(3):222-31. PubMed ID: 10600332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]